Avicena Announces Completion of Patient Enrollment for the First Stage of ALS-08 Phase II Clinical Trial for ALS
Avicena announced that patient enrollment for the first stage of its Phase II ALS clinical trial has been completed by the trial's lead investigator, Paul H. Gordon, M.D., of the Eleanor and Lou Gehrig MDA/ALS Research Center at Columbia University in New York.